Sclérose en plaques agressive: Définition et indication thérapeutique particulière

[1]  R. Gonsette.  Mitoxantrone in progressive multiple sclerosis: when and how to treat? , 2003, Journal of the Neurological Sciences.

[2]  H. Hartung,et al.  Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial , 2002, The Lancet.

[3]  D. Goodkin,et al.  A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis , 2002, Multiple sclerosis.

[4]  D. Goodkin,et al.  Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS , 2002, Neurology.

[5]  G. Edan.  Traitement des formes évolutives de SEP , 2001 .

[6]  A. Gass,et al.  Escalating immunotherapy of multiple sclerosis , 2004, Journal of Neurology.

[7]  C. Pozzilli,et al.  Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome , 1997, Journal of Neurology.

[8]  E. Cabanis,et al.  Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[9]  R. Knobler,et al.  Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. , 1987, Clinical immunology and immunopathology.

[10]  S. Levine,et al.  Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone , 1986, Journal of Neuroimmunology.

[11]  S. Dejoy,et al.  Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function. , 1986, Journal of immunology.

[12]  S. Dejoy,et al.  Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. , 1986, Journal of immunology.

[13]  S. Levine,et al.  Suppression of experimental allergic encephalomyelitis by mitoxantrone. , 1985, Clinical immunology and immunopathology.